OPKO HEALTH, INC.

For the period ended Mar 31, 2025. Filed May 1, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 1, 2025

OPK$1.71-1.2%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

March

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except share and per share data)

	For the three months ended March 31,
	2025	2024
Revenues:
Revenue from services	$102,844	$126,890
Revenue from products	34,842	38,047
Revenue from transfer of intellectual property and other	12,266	8,749
Total revenues	149,952	173,686
Costs and expenses:
Cost of service revenue	84,518	109,873
Cost of product revenue	22,814	21,744
Selling, general and administrative	59,086	70,167
Research and development	30,841	21,937
Amortization of intangible assets	19,861	21,437
Total costs and expenses	217,120	245,158
Operating loss	(67,168)	(71,472)
Other income and (expense), net:
Interest income	4,681	813
Interest expense	(15,466)	(7,686)
Fair value changes of derivative instruments, net	(273)	(26,161)
Other income, net	4,852	21,323
Other expense, net	(6,206)	(11,711)
Loss before income taxes and investment losses	(73,374)	(83,183)
Income tax benefit	5,770	1,350
Net loss before investment losses	(67,604)	(81,833)
Loss from investments in investees	(9)	(3)
Net loss	$(67,613)	$(81,836)
loss per share:
Loss per share, basic and diluted	$(0.10)	$(0.12)
Weighted average common shares outstanding, basic and diluted	671,577,429	706,882,189

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.